Beta test rollout. This site is in community QA — please send feature requests, bug reports and data corrections on the Feedback page or on GitHub.

Home
    Disclaimer
    MBDB molecular structure

    MBDB Stats & Data

    Eden Methyl-j
    PubChem
    MW207.27
    FormulaC12H17NO2
    LogP2.7
    IUPAC1-(1,3-benzodioxol-5-yl)-N-methylbutan-2-amine
    SMILESCCC(CC1=CC2=C(C=C1)OCO2)NC
    InChIKeyUSWVWJSAJAEEHQ-UHFFFAOYSA-N
    Chemical Class Substituted amphetamine
    Psychoactive Class Psychedelic / Stimulant

    Effect Profile

    Curated + 13 Reports
    Psychedelic 2.4

    Mild visuals with strong body load, low headspace

    Visual Intensity×3
    5
    Headspace Depth×3
    1
    Auditory Effects×1
    0
    Body Load / Somatic Effects×1
    9
    Empathogen 4.6

    Moderate stimulation, sensory enhancement, and euphoria with low empathy

    Empathy / Social Openness×3
    2
    Euphoria / Mood Elevation×2
    6
    Stimulation×1
    7
    Sensory Enhancement×1
    7
    Stimulant 4.8

    Moderate stimulation and euphoria with strong anxiety/jitters, mild focus

    Stimulation / Energy×3
    6
    Euphoria / Mood Lift×2
    6
    Focus / Productivity×2
    4
    Anxiety / Jitters×1
    10

    Tolerance & Pharmacokinetics

    drugs.wiki

    Tolerance Decay

    Full tolerance 1h Half tolerance 10d Baseline ~14d

    Experience Report Analysis

    Erowid
    15 Reports
    13 Single-substance
    1995–2004 Date Range
    17 Effects Detected

    Demographics

    Gender Distribution

    Too few reports for a chart: gender is known from 15 reports, and a split is drawn only from 20 reports or more. Counts are shown instead. Why 20?

    • Male 15 of 15

    Reports Over Time

    Effect Analysis

    Erowid

    Effects aggregated from 13 experience reports (13 single-substance Erowid)

    13 Reports
    17 Effects Detected
    9 Positive
    6 Adverse
    2 Neutral

    Effect Sentiment Distribution

    Confidence Distribution

    Each bar is the share of reports mentioning the effect; its whisker, and the band on the rows below, is the 95% interval: where the share could plausibly be with other reports of the same kind.

    Too few reports for bars: these effects come from 13 single-substance Erowid reports, and a bar is drawn only from 20 reports or more. With fewer, a percentage cannot tell a common effect from a rare one. Counts are shown instead. Why 20?

    Positive Effects 9

    Introspection 7 of 13 70%
    Empathy 7 of 13 70%
    Euphoria 6 of 13 70%
    Tactile Enhancement 6 of 13 70%
    Visual Distortions 5 of 13 70%
    Music Enhancement 5 of 13 70%
    Closed-Eye Visuals 3 of 13 70%
    Stimulation 3 of 13 70%
    Color Enhancement 3 of 13 70%

    Adverse Effects 6

    Jaw Clenching 5 of 13 70%
    Confusion 4 of 13 70%
    Anxiety 4 of 13 70%
    Headache 4 of 13 70%
    Sweating 4 of 13 70%
    Pupil Dilation 3 of 13 70%
    Show 2 neutral or unclassified mentions
    Sedation 3 of 13
    Auditory Effects 3 of 13

    Real-World Dose Distribution

    Erowid

    From 14 of 19 recorded dose entries: those that state a weight (mg, g or µg), in routes with at least five of them. Values above Q3 + 3×IQR, far above what people typically take, are left out; they can include real heavy doses and overdoses, not only mistakes.

    Oral (n=13)

    Median: 185.0mg 25th: 180.0mg 75th: 200.0mg 90th: 250.0mg

    Form / Preparation

    Most common forms and preparations, as a share of the 13 reports that give one

    Too few reports for bars: these forms come from 13 reports, and a bar is drawn only from 20 reports or more. With fewer, a percentage cannot tell a common effect from a rare one. Counts are shown instead. Why 20?

    • Powder / Crystals 10 of 13
    • Capsule 2 of 13

    Body-Weight Dosing

    Dose per kg of body weight, one dose per report (the first listed), from reports giving a weight of 30–250 kg. Doses above Q3 + 3×IQR, far above what people typically take, are left out of the median and range and listed under each route.

    Median: 2.841 mg/kg IQR: 2.426–3.429 mg/kg n=8

    Redose Patterns

    Redosing behavior across 13 reports

    3 of 13 Redosed
    1.2 Avg Doses

    Too few reports for a chart: redosing is known from 13 reports, and a split is drawn only from 20 reports or more. Counts are shown instead. Why 20?

    • Single dose 10 of 13
    • Redosed 3 of 13
    ← Back to MBDB